Drug Profile
Hepatitis B vaccine - Chongqing Jiachen
Alternative Names: Epsilon-PA-44; PA-44Latest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator Chongqing Jiachen Biotechnology
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 06 Jun 2012 Chongqing Jiachen Biotechnology completes enrolment in its Phase-II trial for Hepatitis B (combination therapy) in China (NCT01326546)
- 30 Nov 2011 Chongqing Jiachen Biotechnology completes a phase II trial in Hepatitis B in China (NCT00869778)
- 30 Jun 2010 Phase-II clinical trials in Hepatitis B (combination therapy) in China (SC)